Hilary L. Lewis counsels clients on US Food and Drug Administration (FDA), US Department of Agriculture (USDA), Federal Trade Commission (FTC), and state regulatory compliance issues involving food and dietary supplements, over-the-counter and prescription drug products, and cosmetics. Hilary applies her background litigating on behalf of FDA-regulated companies to assist clients in their defense against FDA, USDA, and Consumer Product Safety Commission (CPSC) enforcement actions, and has helped companies resolve import detentions, manage product recalls and corrective actions, and navigate Food Safety and Inspection Service (FSIS) investigations.
Hilary also advises clients on due diligence for transactional matters involving FDA-regulated company acquisitions and initial public offerings, as well as on labeling and promotional activities under the Federal Food, Drug, and Cosmetic Act and the FTC Act.
Georgetown University Law Center, 2012, J.D.
Harvard College, 2008, A.B.
District of Columbia
U.S. District Court for the District of Columbia
U.S. District Court for the Southern District of New York
Awards and Affiliations
Member, Food and Drug Law Journal Editorial Advisory Board (2019)